Clincosm LogoSign in Get a demo

Chronic Lymphocytic Leukemia (CLL)

Showing NaN - NaN of 13
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Lymphocytic Leukemia (CLL) Trial in United States (Venetoclax, Obinutuzumab, Acalabrutinib)

Active, not recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • Stamford, Connecticut
  • +4 more
Dec 2, 2022

Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Leukemia (SLL) Trial in United States (Zanubrutinib, Obinutuzumab,

Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • Small Lymphocytic Leukemia (SLL)
  • Evanston, Illinois
  • +7 more
Sep 9, 2022

Follicular Lymphoma (FL), Mantle Cell Lymphoma (MCL), Marginal Zone Lymphoma (MZL) Trial in United States (voruciclib

Recruiting
  • Follicular Lymphoma (FL)
  • +6 more
  • voruciclib monotherapy
  • voruciclib and venetoclax
  • Duarte, California
  • +10 more
Aug 10, 2022

Chronic Lymphocytic Leukemia (CLL) Trial in Worldwide (Venetoclax, Obinutuzumab)

Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • La Jolla, California
  • +41 more
Aug 10, 2022

Chronic Lymphocytic Leukemia (CLL) Trial in Boston (Ibrutinib, Copanlisib, Acalabrutinib)

Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
May 13, 2022

MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular

Recruiting
  • Monoclonal Gammopathy of Undetermined Significance (MGUS)
  • +8 more
    • Boston, Massachusetts
    • +6 more
    Apr 14, 2022

    Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma Trial in Boston (Venetoclax, Zanubrutinib)

    Recruiting
    • Chronic Lymphocytic Leukemia (CLL)
    • Small Lymphocytic Lymphoma
    • Boston, Massachusetts
    • +2 more
    Mar 16, 2022

    Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Follicular Lymphoma (FL) Trial in Switzerland, United

    Recruiting
    • Chronic Lymphocytic Leukemia (CLL)
    • +6 more
    • Tucson, Arizona
    • +23 more
    Dec 14, 2021

    Cutaneous T-cell Lymphoma (CTCL), Mycosis Fungoides (MF), Chronic Lymphocytic Leukemia (CLL) Trial in United States (Cobomarsen)

    Completed
    • Cutaneous T-cell Lymphoma (CTCL)
    • +4 more
    • Duarte, California
    • +18 more
    Nov 19, 2020

    Chronic Lymphocytic Leukemia (CLL), Non-Hodgkin's Lymphoma (NHL) Trial in United States (TRU-016 (anti-CD37 protein

    Completed
    • Chronic Lymphocytic Leukemia (CLL)
    • Non-Hodgkin's Lymphoma (NHL)
    • TRU-016 (anti-CD37 protein therapeutic)
    • Birmingham, Alabama
    • +6 more
    Jun 26, 2017

    Chronic Kidney Disease, Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL) Trial in Boston (Haploidentical Bone

    Unknown status
    • Chronic Kidney Disease
    • +16 more
    • Haploidentical Bone Marrow/Kidney
    • Boston, Massachusetts
      Massachusetts General Hospital
    Mar 21, 2017

    Non-Hodgkin's Lymphoma (NHL), Hodgkin's Disease, Chronic Lymphocytic Leukemia (CLL) Trial in Boston, Columbus (Single FT1050

    Completed
    • Non-Hodgkin's Lymphoma (NHL)
    • +4 more
    • Single FT1050 treated UCB unit
    • Boston, Massachusetts
    • +2 more
    Sep 9, 2016

    Chronic Lymphocytic Leukemia (CLL), Lymphoma, Non-Hodgkin (NHL), Acute Myeloid Leukemia (AML) Trial in United States (CAL-101)

    Completed
    • Chronic Lymphocytic Leukemia (CLL)
    • +3 more
    • Palo Alto, California
    • +8 more
    Aug 29, 2012